课题基金 / 基金详情

Microbial Ecology-Guided Discovery of Antibacterial Drugs

Microbial Ecology-Guided Discovery of Antibacterial Drugs
微生物生态学引导抗菌药物的发现
批准号:
10565917
负责人:
Eric W Schmidt
金额:
$63.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-02-07 至 2027-01-31

项目摘要

项目成果

Eric W Schmidt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Multidrug-resistant bacteria are an increasing health threat. Most new antibacterial agents are natural products that are made by bacteria, or their synthetic derivatives. This is because, over evolutionary time, bacteria gain the ability to synthesize small molecules that very selectively target essential processes in other bacteria. One problem in identifying good antibacterial agents that are relatively nontoxic to people is that early drug discovery assays cannot determine whether compounds are truly selective until well into the drug development process. There is no reason that randomly cultivated bacteria from the environment would produce chemicals that are benign in humans, yet lethal to competing bacteria. Finding those compounds, or improving existing compounds to minimize toxicity and improve antibacterial activity, requires a significant investment. Here, we propose to examine symbiotic bacteria that are compatible with animal physiology, and for which evolution favors the production of selective antibacterial agents. The bacteria are enriched within animal hosts, where they produce hundreds or perhaps thousands of small molecule natural products. One of the main ecological roles of the symbiotic bacteria is likely to clear other bacteria from the host. Proof-of-concept experiments demonstrate that the bacteria produce nontoxic compounds that very selectively target human pathogens, including some of the most lethal bacterial pathogens that infect humans. In this program, we will optimize identified, chemically novel antibacterial compounds by understanding their mechanisms of action and by investigating and improving their existing properties further through chemical synthesis. Further, we will continue to identify and characterize promising new antibacterial agents that are previously unknown to science. Our long-term goal is to provide a novel pipeline of new antibacterial agents to combat multidrug resistance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Symbiosis and Chemical Diversity Generation
  • 批准号:
    10552461
  • 项目类别:
  • 资助金额:
    $53.96万
  • 财政年份:
    2023
  • 负责人:
    Eric W Schmidt
  • 依托单位:
Modulating single cell types in the sensory nervous system
  • 批准号:
    10522412
  • 项目类别:
  • 资助金额:
    $54.21万
  • 财政年份:
    2022
  • 负责人:
    Eric W Schmidt
  • 依托单位:
Microbial Ecology-Guided Discovery of Antibacterial Drugs
  • 批准号:
    10446908
  • 项目类别:
  • 资助金额:
    $66.48万
  • 财政年份:
    2022
  • 负责人:
    Eric W Schmidt
  • 依托单位:
Modulating single cell types in the sensory nervous system
  • 批准号:
    10641952
  • 项目类别:
  • 资助金额:
    $54.21万
  • 财政年份:
    2022
  • 负责人:
    Eric W Schmidt
  • 依托单位:
海外基金